|
|
|
| Clinical effect of ultrasound combined with Felbinac Gel in the treatment of myositis ossificans traumatica |
| SONG Yixin1,2* LV Xiangwei3* LIU Xifang1 WU Longchang4▲ WANG Hanghui1,2▲ |
1.The Second Ward of Traditional Chinese Medicine Orthopedics, Honghui Hospital, Xi′an Jiaotong University, Shaanxi Province, Xi′an 710054, China;
2.Xi′an International University, Shaanxi Province, Xi′an 710077, China;
3.Department of Orthopedics, Qishan Traditional Chinese Medicine Hospital, Shaanxi Province, Qishan 722499, China;
4.Department of Orthopedics, Xi′an Weiyang District Hospital of Traditional Chinese Medicine, Shaanxi Province, Xi′an 710016, China |
|
|
|
Abstract Objective To evaluate the clinical efficacy of combining ultrasound with Felbinac Gel in myositis ossificans traumatica, and to explore the effective rehabilitation approaches of myositis ossificans. Methods Clinical data of 32 patients with myositis ossification (experimental group) and 16 patients with non-myositis ossification during the same period (control group) in Honghui Hospital, Xi′an Jiaotong University from September 2015 to September 2017 were retrospectively analyzed. The X-ray and clinical symptoms, alkaline phosphatase, pain scores, joint activity and patient satisfaction were observed respectively by way of combining ultrasound with Felbinac Gel penetration method. Results After the treatment of ultrasound combined with Felbinac Gel, the clinical symptoms and X-ray of patients were improved, and alkaline phosphatase was reduced significantly 1 month after treatment, as well as the pain scores（P < 0.05）. Meanwhile, the joint activity and joint function scores were superior to those of pre-therapy, and patients′ satisfaction was improved（P < 0.05）. Conclusion The method of ultrasound combined with Felbinac Gel can effectively promote the recovery of joint function and relieve pain of patients with myositis ossificans traumatica. The rehabilitation approach is safe, effective and without side effect. It is worthy of wide application.
|
|
|
|
|
|
[1] Reinke A，Kraus M，Wild A. Myositis Ossificans Traumatica in the Craniocervical Junction：A Case Report and Review of Literature [J]. Z Orthop Unfall，2017，155（3）：328-332.
[2] Simon T，Guillodo Y，Madouas G，et al. Myositis ossificans traumatica （circumscripta） and return to sport：A retrospective series of 19 cases [J]. Joint Bone Spine，2016，83（4）：416-420.
[3] Kanthimathi B，Udhaya Shankar S，Arun Kumar K，et al. Myositis ossificans traumatica causing ankylosis of the elbow [J]. Clin Orthop Surg，2014，6（4）：480-483.
[4] Muir B.Myositis ossificans traumatica of the deltoid ligament in a 34 year old recreational ice hockey player with a 15 year post-trauma follow-up：a case report and review of the literature [J]. J Can Chiropr Assoc，2010，54（4）：229-242.
[5] Wilkes LL. Myositis ossificans traumatica in a young child：a case report [J]. Clin Orthop Relat Res，1976，118：151-152.
[6] Parikh J，Hyare H，Saifuddin A. The imaging features of post-traumatic myositis ossificans，with emphasis on MRI [J]. Clin Radiol，2002，57（12）：1058-1066.
[7] Beiner JM，Jokl P. Muscle contusion injury and myositis ossificans traumatica [J]. Clin Orthop，2002，403S：S110-S119.
[8] Demir MK，Beser M，Akinei O. Case 118：Proliferative myositis [J]. Radiology，2007，244（2）：613-616.
[9] Bourdel N，Alves J，Pickering G，et al. Systematic review of endometriosis pain assessment：how to choose a scale? [J]. Human Reproduction Update，2014，21（1）：136-152.
[10] Sinha S，Schreiner AJ，Biernaskie J，et al. Treating pain on skin graft donor sites：review and clinical recommendations [J].J Trauma Acute Care Surg，2017，83（5）：954-964.
[11] Modabber MR，Jupiter JB. Reconstruction for post traumatic condition of the elbow joint [J]. J Bone Joint Sury Am，1995，77（9）：1431-1446．
[12] 杜路，孙银娣.肘关节骨化性肌炎的蜡疗观察[J].美中国际创伤杂志，2010，9（2）：22-23.
[13] 蒋协远，王大伟．骨科临床疗效评价标准[M].北京：人民卫生出版社，2005.
[14] 陈罗西，刘波，张晓芳，等.传统关节黏连松解术联合中药内服外敷治疗骨化性肌炎并发关节僵硬[J].中医正骨，2017，29（4）：76-78.
[15] Gozo MC1，Aspuria PJ，Cheon DJ，et al. Foxc2 induces Wnt4 and Bmp4 expression during muscle regeneration and osteogenesis [J]. Cell Death Differ，2013，20（8）：1031-1042.
[16] Yu PB，Deng DY，Lai CS，et al. BMP type I receptor inhibition reduces heterotopic [corrected] ossification [J]. Nat Med，2008，14（12）：1363-1369.
[17] Walczak BE，Johnson CN，Howe BM. Myositis Ossificans [J]. J Am Acad Orthop Surg，2015，23（10）：612-622.
[18] Hatsell SJ. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A [J]. Sci Transl Med，2015，7：303ra137.
[19] Katagiri T. A Door Opens for Fibrodysplasia Ossificans Progressiva [J]. Trends Biochem Sci，2016，41（2）：119-121.
[20] 刘晓冬.非甾体类药预防性治疗肘部外伤术后并发骨化性肌炎[J].创伤外科杂志，2011，13（4）：322-323.
[21] Fijn R，Koorevaar RT，Brouwers JR. Prevention of heterotopic ossification after total hip replacement with NSAIDs [J]. Pharm World Sci，2003，25（4）：138-145.
[22] Rath E，Warschawski Y，Maman E，et al. Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery [J]. Am J Sports Med，2016，44（3）：677-681.
[23] Bagnulo A，Gringmuth R. Treatment of Myositis Ossificans with acetic acid phonophoresis：a case series [J]. J Can Chiropr Assoc，2014，58（4）：353-360.
[24] 徐小梅.醋酸泼尼松龙注射液超声透入治疗骨化性肌炎1例[J].中国疗养医学，2005，14（5）：359. |
|
|
|
